$1.92 0.02 (+1.05%)
11/25/2009 4:00 PM

Idenix Pharmaceuticals, Inc. (IDIX)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.

Featured Broker Partners